oleic acid has been researched along with Disease Exacerbation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dębska-Ślizień, A; Kaczkan, M; Małgorzewicz, S; Rutkowski, P; Stachowska, E; Szczuko, M | 1 |
| Brown, MV; Cheatham, B; Compton, SA; Lawton, KA; Milburn, MV | 1 |
| Bellenghi, M; Bottero, L; Carè, A; Colombo, MP; De Feo, A; Denaro, M; Errico, MC; Felicetti, F; Felli, N; Gesumundo, C; Mattia, G; Pasquini, L; Pedini, F; Petrini, M; Puglisi, R; Sangaletti, S; Tripodo, C | 1 |
| Liao, W; Liu, Y; Ma, H; Shao, X; Shi, M; Xing, MM; Zhong, W | 1 |
| Fujii, K; Fujiwara, R; Kadochi, Y; Kishi, S; Kuniyasu, H; Mori, S; Nishiguchi, Y; Ohmori, H; Sasaki, T | 1 |
| Gil Cano, A; Gracia Romero, M; Guijo González, P; Monge García, MI; Ruiz Campos, J | 1 |
| Beaufrère, B; Chardigny, JM; Fernie, CE; Lassel, TS; Loreau, O; Malpuech-Brugère, C; Maret, A; Mensink, RP; Scrimgeour, CM; Sébédio, JL | 1 |
| Abe, M; Abe, T; Akiyama, Y; Ito, S; Moriguchi, T; Sato, H; Shibata, E; Souma, T; Suzuki, T; Takai, J; Tanemoto, M; Toyohara, T; Yamamoto, M; Yanagisawa-Miyazawa, N | 1 |
| Chase, JG; Chiew, YS; Desaive, T; Janssen, N; Lambermont, B; Moeller, K; Schranz, C; Shaw, GM | 1 |
| Caffall, Z; Ferguson, DC; Hoenig, M | 1 |
| Gerrity, RG; Kimsey, T; Nadler, JL; Natarajan, R | 1 |
1 trial(s) available for oleic acid and Disease Exacerbation
| Article | Year |
|---|---|
Comparison of postprandial oleic acid, 9c,11t CLA and 10t,12c CLA oxidation in healthy moderately overweight subjects.
Topics: Adult; Disease Progression; Double-Blind Method; Female; Health; Humans; Isomerism; Linoleic Acids, Conjugated; Lipid Metabolism; Male; Middle Aged; Oleic Acid; Overweight; Oxidation-Reduction; Placebos; Postprandial Period | 2010 |
10 other study(ies) available for oleic acid and Disease Exacerbation
| Article | Year |
|---|---|
The C18:3n6/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression.
Topics: Aged; Biomarkers; Chromatography, Gas; Disease Progression; Fatty Acids; Fatty Acids, Monounsaturated; Female; Humans; Male; Middle Aged; Oleic Acid; Poland; Prospective Studies; Renal Insufficiency, Chronic | 2020 |
Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression.
Topics: Bile Acids and Salts; Diglycerides; Disease Progression; Fatty Liver; HEK293 Cells; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Liver; Metabolome; Mitochondria; Monoglycerides; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Palmitic Acid; Phosphorylation; Reactive Oxygen Species | 2013 |
SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.
Topics: Cathepsin B; Cell Line, Tumor; Disease Progression; Down-Regulation; Fatty Acids; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Intracellular Space; Melanocytes; Melanoma; Oleic Acid; Osteonectin; Stearoyl-CoA Desaturase | 2015 |
Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Disease Progression; Doxorubicin; Drug Carriers; Drug Liberation; Ferric Compounds; Folic Acid; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; Magnetite Nanoparticles; Magnets; Male; Mice; Mice, Nude; Oleic Acid; Stomach Neoplasms; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2015 |
Elaidic Acid, a Trans-Fatty Acid, Enhances the Metastasis of Colorectal Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Oleic Acid; Oleic Acids; Trans Fatty Acids | 2017 |
Preemptive hemodynamic intervention restricting the administration of fluids attenuates lung edema progression in oleic acid-induced lung injury.
Topics: Animals; Disease Progression; Fluid Therapy; Hemodynamics; Lung Injury; Oleic Acid; Pulmonary Edema; Rabbits; Random Allocation; Respiration, Artificial | 2017 |
Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells.
Topics: Albumins; Animals; Apoptosis; Cell Line; Disease Models, Animal; Disease Progression; DNA Damage; Female; Focal Adhesion Kinase 2; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oleic Acid; Oxidative Stress; Oxygen; Proteinuria; Reactive Oxygen Species; Sodium Bicarbonate | 2011 |
Physiological relevance and performance of a minimal lung model: an experimental study in healthy and acute respiratory distress syndrome model piglets.
Topics: Animals; Disease Models, Animal; Disease Progression; Lung; Models, Biological; Oleic Acid; Positive-Pressure Respiration; Respiratory Distress Syndrome; Respiratory Mechanics; Swine | 2012 |
Obesity increases free thyroxine proportionally to nonesterified fatty acid concentrations in adult neutered female cats.
Topics: Animals; Cats; Diabetes Mellitus, Type 2; Disease Progression; Fatty Acids, Nonesterified; Female; Insulin Resistance; Leptin; Models, Animal; Obesity; Oleic Acid; Ovariectomy; Palmitic Acid; Thyrotropin; Thyroxine; Triiodothyronine | 2007 |
Diabetes-induced accelerated atherosclerosis in swine.
Topics: Acetates; Animals; Arteriosclerosis; Blood Glucose; Cholesterol; Cholesterol Esters; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Islets of Langerhans; Lipids; Monocytes; Oleic Acid; Risk Factors; Streptozocin; Swine; Triglycerides | 2001 |